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Abstract
Background: Natural resistance associated macrophage protein 1 (NRAMP1), encoded by the SLC11A1 gene, has been
described to regulate macrophage activation and be associated with infectious and autoimmune diseases. The relation
between SLC11A1 polymorphisms and tuberculosis susceptibility has been studied in different populations.
Methods: We systematically reviewed published studies on SLC11A1 polymorphisms and tuberculosis susceptibility until
September 15, 2010 and quantitatively summarized associations of the most widely studied polymorphisms using meta-
analysis.
Results: In total, 36 eligible articles were included in this review. In Meta-analysis, significant associations were observed
between tuberculosis risk and widely studied SLC11A1 polymorphisms with summarized odds ratio of 1.35 (95%CI, 1.17–
1.54), 1.25 (95% CI, 1.04–1.50), 1.23 (95% CI, 1.04–1.44), 1.31 (95%CI, 1.08–1.59) for 39 UTR, D543N, INT4, and 59 (GT)n,
respectively. Heterogeneity between studies was not pronounced, and the associations did not remarkably vary in the
stratified analysis with respect to study population and study base.
Conclusions: The association between SLC11A1 polymorphisms and tuberculosis susceptibility observed in our analyses
supports the hypothesis that NRAMP1 might play an important role in the host defense to the development of tuberculosis.
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Introduction
Host genetic susceptibility to infectious disease has been widely
studied in recent years, which is helpful for high-risk population
identification and therefore promotes diseases prevention and
early diagnosis [1,2]. Moreover, such study also contributes to
clarify potential mechanisms underlying host defense to the disease
development. Natural resistance associated macrophage protein 1
(NRAMP1), encoded by the SLC11A1 gene, has multiple effects on
macrophage activation and has been reported to play an
important role in host innate immune response against infections
[3].
Tuberculosis (TB), caused by infection of Mycobacterium
tuberculosis, remains a major challenge to global public health. As
estimated, that one-third of the world’s population is infected, but
that only a minority of those infected ever develop TB [4]. Host
genetic susceptibility, together with some environmental and
lifestyle factors, has been suggested to contribute to such clinical
diversity [5,6]. In 1998, for the first time, relation between
SLC11A1 polymorphisms and TB susceptibility was reported in a
population from West Africa [7]. Later, the association of several
SLC11A1 loci have been extensively investigated, including 39
UTR (1729+55del4), D543N (Asp543Asn), INT4 (469+14G/C),
and 59 promoter (GT)n. However, the results were not consistent
between the studies. A meta-analysis, which based on literature
review until December 2004, suggested an ethnicity specific effect
of SLC11A1 polymorphisms on TB risk [8]. In the past five years,
the number of original studies addressing this topic has doubled.
Therefore, it is necessary to update the meta-analysis which might
provide more solid evidence and minimize potential bias caused by
limited publications in the past.
In this article, we performed a systematic review and meta-
analysis, based on literature identification until 15 September
2010, to summarize associations between the most widely studied
SLC11A1 polymorphisms and TB susceptibility.
Results
A total of 336 articles were achieved by literature search, from
the PubMed, EMBASE and CBM databases, using different
combination of key terms. As shown in Figure 1, after excluding
those overlapped between the databases, 217 abstracts were
retrieved for detailed evaluation. Forty seven studies addressing
the association of SLC11A1 polymorphisms and TB were
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refer to Table S1 for more detailed information). Finally, 38
studies from 36 articles, 29 in English [7,9–36]and 7 in Chinese
[37–43], were included in this review and meta-analysis.
As shown in Table S2 and Table S3, among the included
articles, 25 were conduced in Asians and 11 in non-Asians (3 from
Africa, 4 from Europeans and 2 from Americans). Thirteen studies
and 3 studies specifically addressed pulmonary TB and extra-
pulmonary TB, respectively. Seven studies were population based.
HIV status of the studied population was considered in 24 studies.
There were 13 studies matched controls with cases for major
covariates (age, sex, ethnicity, and area of residence). For 39 UTR,
D543N, INT4 and 59 (GT)n, meta-analyses were conduced within
30, 29, 20 and 12 studies, respectively.
Figure 2 shows the associations between SLC11A1 39 UTR
polymorphism and TB. Meta-analysis suggested that TGTG-
carriage (TGTG2/2 and TGTG2/+) might be a risk factor for
TB with a summarized OR of 1.35 (95%CI, 1.17–1.54) as
compared to TGTG+/+ genotype. Medium heterogeneity
between studies (p,0.01; I
2=48.41%) was observed. No evident
publication bias was found (p=0.99 for Begg rank correlation
analysis; p=0.59 for Egger weighted regression analysis). In the
stratified analysis, the strength of the association was most evident
for Asians, and marginal results were observed for Africans and
Westerns. No pronounced difference was found according to
different study base.
As shown in Figure 3, good homogeneity was observed between
studies addressing D543N polymorphism (p,0.01; I
2=61.26%)
and A allele carriage was significantly associated with TB (OR,
1.24; 95% CI, 1.04–1.49). No substantial publication bias was
observed (p=0.39 for Begg rank correlation analysis; p=0.49 for
Egger weighted regression analysis). In the subgroup analyses,
significant relations were observed for Africans and Westerns.
As shown in Figure 4, a significant association was found for
INT4 C allele carriage (CC+CG) with increased risk of TB as
compared to GG genotype (OR, 1.23; 95% CI, 1.04–1.44).
Medium heterogeneity between studies (p=0.08; I
2=32.47%) was
observed. No significant publication bias was observed (p=0.12
for Begg rank correlation analysis; p=0.35 for Egger weighted
regression analysis). The association was not significant any more
in Westerns in the subgroup analysis.
Meta-analysis of the association between TB and SLC11A1 59
promoter (GT)n polymorphism was shown in Figure 5. As compared
to the most commonly distributed allele 3, carriage of other alleles
wassignificantlyrelatedtoanincreasedriskofTBwith asummarized
OR of 1.31 (95%CI, 1.08–1.59). No substantial heterogeneity was
observed between studies (p,0.01; I
2=61.78%). No publication bias
was found (p=0.49 for Begg rank correlation analysis; p=0.51 for
Figure 1. Flow diagram of study identification.
doi:10.1371/journal.pone.0015831.g001
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results were observed between subgroups according to study base,
and significant association was found only for Africans.
After excluding studies specifically addressing extra-pulmonary
TB, the associations between SLC11A1 polymorphisms and TB
were not substantially changed (see Table S4). Similar associa-
tions were observed as well when stratified the analysis on
pulmonary TB (see Table S4), which suggests the effect of
SLC11A1 polymorphisms might not be influenced by disease
types.
Figure 2. Meta-analysis of the association between tuberculosis and SLC11A1 39 UTR polymorphism (*TGTG- vs. TGTG+/+).
a=subgroup of patients with spinal tuberculosis; b=subgroup of patients with pulmonary tuberculosis; c=subgroup of patients who were
aboriginal Taiwanese; d=subgroup of patients who were Hans; CI=confidence interval; OR=odds ratio.
doi:10.1371/journal.pone.0015831.g002
SLC11A1 Polymorphisms and TB
PLoS ONE | www.plosone.org 3 January 2011 | Volume 6 | Issue 1 | e15831Discussion
This review addressed the associations between SLC11A1 poly-
morphisms and TB susceptibility reported until September 2010.
Thirty six articles addressing the most widely studied SLC11A1
polymorphisms (39 UTR, D543N, INT4 and 59 (GT)n) were
identified, and their effects were summarized by means of meta-
analysis. Significant associations with TB susceptibility were observed
for all these four loci. Strength of the associations in the subgroup
analyseswith respect to studypopulation wasnot consistent. However,
significant association has been observed for all populations (Africans,
Asians and Westerns) with at least one of the four loci. Limited
Figure 3. Meta-analysis of the association between tuberculosis and SLC11A1 D543N polymorphism (*A vs. GG). a=subgroup of
patients with spinal tuberculosis; b=subgroup of patients with pulmonary tuberculosis; c=subgroup of patients who were aboriginal Taiwanese;
d=subgroup of patients who were Hans; CI=confidence interval; OR=odds ratio.
doi:10.1371/journal.pone.0015831.g003
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studies might explain, at least in part, the existing inconsistency.
TB is a serious public health problem in worldwide. Early
diagnosis, drug resistance, vaccine and HIV co-infection are major
factors influencing efficiency of TB prevention and control [44]. In the
past decades, the association between host genetic polymorphisms
and TB susceptibility has been widely studied as well. Most of the
target loci were localized in genes participating immune response
[45]. The NRAMP1 protein is an integral membrane protein
expressed exclusively in the lysosomal compartment of monocytes and
macrophages [3]. It has been reported that NRAMP1 regulates
macrophage activation and is associated with TB susceptibility.
Underlying mechanisms have been proposed based on its function as
metal transporter [46]. After phagocytosis, NRAMP1 is targeted to
the membrane of the microbe-containing phagosome, where it
mediates transport of iron and other cations. Iron is essential for
biological functions, both for host immune defense and mycobacterial
growth. Therefore, NRAMP1 has also been suggested to play a role in
determining host susceptibility to other intracellular pathogens and
autoimmune diseases [47]. Positive association between SLC11A1
polymorphisms and these infections and diseases has provided strong
evidence for this hypothesis.
In 2006, Li HT and colleagues reported a meta-analysis on
SLC11A1 polymorphisms and TB which based on 14 eligible
studies published until December 2004 [8]. In this article, less
common alleles at the four most widely studied loci were generally
Figure 4. Meta-analysis of the association between tuberculosis and SLC11A1 INT4 polymorphism (*C vs. GG). c=subgroup of patients
who were aboriginal Taiwanese; d=subgroup of patients who were Hans; CI=confidence interval; OR=odds ratio.
doi:10.1371/journal.pone.0015831.g004
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and Asian, whereas they were not statistically associated with TB in
those of European origin. Authors suggested this ethnic-specific
observation may explain in part by Africans and Asians have greater
susceptibility to TB than those of Europeans. Meanwhile, authors also
mentioned that this hypothesis needed to be proved in future research
due to the limited number of included publications and subjects. Our
present updated meta-analysis, based on 36 eligible studies until
September 2010, did not present an ethic-specific effect of SLC11A1
polymorphisms. Three ethnic groups were defined with respect to the
distribution of study population in the included studies, e.g. Asians,
Africans and Westerns (Europeans and Americans). Statistically
significant or marginal associations with TB susceptibility were found
forthe fourstudied lociin all of the three ethnic groups.Large number
of included articles in the present study makes the evidence stronger to
propose a consistent effect of SLC11A1 polymorphisms in different
populations. In addition, population-based study has shown to be
more powerful for such genetic association analysis. However, only
minority of included studies (7 of 36) were conducted as population-
based and no substantial different or more pronounced effect was
observed as compared to those hospital-based studies.
The stratified analyses suggested different study population and
study base might partly explain the moderate heterogeneity
between studies observed in our analyses. Further sensitivity
analyses were performed as well to explore potential origin of the
heterogeneity (see Table S4). When restrict to analyses on
pulmonary TB or excluding those studies specifically on extra-
pulmonary TB, better homogeneity between studies was observed.
Nevertheless, the effects of the polymorphisms were not substan-
tially influenced by such stratified analyses, which suggested that
the role of NRAMP1 in the development of TB might not be
disease type specific. Further studies addressing the effect of
NRAMP1 on pulmonary TB and extra-pulmonary TB, respec-
tively, are warranted to verify this hypothesis.
There are some limitations to this systematic review that should be
kept in mind. First, the potential confounding effect of age, sex and
Figure 5. Meta-analysis of the association between tuberculosis and SLC11A1 59 (GT)n polymorphism (allele 3 vs. other alleles).
c=subgroup of patients who were aboriginal Taiwanese; d=subgroup of patients who were Hans; e=HIV-negative pulmonary TB patients; f=HIV-
negative extra-pulmonary tuberculosis patients; CI=confidence interval; OR=odds ratio.
doi:10.1371/journal.pone.0015831.g005
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which makes the interpretation of the results and stratified analyses
difficult. Second, because not all necessary information could be
obtained from all included studies, more detailed sub-grouping
analysis (e.g. by HIV status or type of TB) could not be performed.
Third, the crude division of ethnics groups into ‘Asian’, ‘African’, and
‘Western’ makes the analyses be prone to bias. Further studies from
different populations are warranted to verify current findings. Fourth,
included studies were restricted to those published in English or
Chinese in our study which might introduce potential bias into data
analysis as well. Fifth, only 17 included studies mentioned whether
their study population was in HWE for the investigated variants
[11,14,16,17,23–30,33–35,39,43]. Based on the data provided by the
articles and own calculations, significant deviations from HWE
(p,0.05) in controls were observed for three studies for any of their
studied polymorphisms [12,38,42]. Their results should be interpreted
with more caution. We therefore repeated the meta-analyses after
exclusion of these studies. However, this exclusion did not materially
a f f e c tt h er e s u l t s( s e eT a b l eS 4 ) .
In conclusion, this systematic review summarized the associa-
tions between SLC11A1 polymorphisms and TB susceptibility. Our
results suggested a consistent association between SLC11A1
polymorphisms and TB in different populations, which supports
the hypothesis that NRAMP1 might play an important role in the
host defense to the development of TB. However, due to the
moderate strength of the associations, their values to be used for
risk prediction should be considered cautiously.
Materials and Methods
Literature search
Studies addressing the association between SLC11A1 polymor-
phisms and TB were identified by searching for articles in the
PubMed, EMBASE and Chinese BioMedical Literature (CBM)
Database until 15 September 2010 [5]. Various combinations of
the terms ‘‘tuberculosis’’, ‘‘NRAMP1’’, ‘‘SLC11A1’’, ‘‘polymor-
phism’’ and ‘‘susceptibility’’ were used to screen for potentially
relevant studies. Additional studies were also identified by means
of cross-referencing.
Inclusion and exclusion criteria
Case-control or cohort studies presenting original data on the
associations between SLC11A1 polymorphisms and TB were
included. Only the most widely studied polymorphisms were
considered: 39 UTR (1729+55del4) (rs17235416), D543N (As-
p543Asn) (rs17235409), INT4 (469+14G/C) (rs3731865), and 59
promoter (GT)n (rs34448891). Exclusion criteria were: 1) review
articles; 2) studies in languages other than English or Chinese; 2)
studies on other polymorphisms other than the target four
polymorphisms; 3) previous articles addressing meta-analysis of
the associations between SLC11A1 polymorphisms and TB. If the
eligible study was reported in duplication, the article published in
English or published earlier was included in this review.
Data extraction
For all studies, we extracted the following data from original
publications: first author and year of publication; distribution of
genotypes for each polymorphism among cases and controls;
characteristics of the study design and the study population (study
base, numbers and mean age of cases and controls, TB diagnosis,
HIV status, source of controls, matching criteria and host ethnicity).
Statistical analysis
Hardy-Weinberg Equilibrium (HWE) was examined in controls
by asymptotic Pearson’s chi-square test for each polymorphism in
each study. The association between polymorphism and TB was
estimated by means of odds ratios (OR) and corresponding 95%
confidence intervals (CI) comparing cases to controls. Co-
dominant model was used for 39 UTR, D543N, and INT4. The
effect of allele 3 carriage was assessed for 59 (GT)n. Meta-analyses
were carried out using Comprehensive Meta-Analysis (V2.0,
Biostat, Englewood, NJ, USA). Random effects models were used
for meta-analysis, taking into account the possibility of heteroge-
neity between studies which was tested by the Q test and I
2 test.
Stratified analyses were conducted with respect to study base
(hospital or population based) and host ethnicity. The latter was
categorized into Africans, Asians and Westerns (Europeans and
Americans). Because of the limited number of publications in
Americans, they were sub-grouped to Westerns combined with
studies from Europeans. Begg rank correlation method and Egger
weighted regression method were used to statistically assess
publication bias (p,0.05 was considered indicative of statistically
significant publication bias). Sensitivity analyses were performed
after excluding studies specifically on extra-pulmonary TB, or
restricting the analysis specifically on pulmonary TB.
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